Simultaneous Analysis of In Vivo CD8+ T Cell Cytotoxicity Against Multiple Epitopes using Multicolor Flow Cytometry

REFERENCES

• Ahonen C. L., Doxsee C. L., McGurran S. M., Riter T. R., Wade W. F., Barth R. J., Vasilakos J. P., Noelle R. J., Kedl R. M. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J. Exp. Med. 2004; 199: 775–784
   PubMed Web of Science ®Google Scholar
• Badovinac V. P., Harty J. T. Intracellular staining for TNF and IFN-gamma detects different frequencies of antigen-specific CD8(+) T cells. J. Immunol. Meth. 2000; 238: 107–117
   PubMed Web of Science ®Google Scholar
• Barber D. L., Wherry E. J., Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 2003; 171: 27–31
   PubMed Web of Science ®Google Scholar
• Betts M. R., Brenchley J. M., Price D. A., De Rosa S. C., Douek D. C., Roederer M., Koup R. A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Meth. 2003; 281: 65–78
   PubMed Web of Science ®Google Scholar
• Botten J., Alexander J., Pasquetto V., Sidney J., Barrowman P., Ting J., Peters B., Southwood S., Stewart B., Rodriguez-Carreno M. P., et al. Identification of protective Lassa virus epitopes that are restricted by HLA-A2. J. Virol. 2006; 80: 8351–8361
   PubMed Web of Science ®Google Scholar
• Botten J., Whitton J. L., Barrowman P., Sidney J., Whitmire J. K., Alexander J., Ting J. P., Bui H. H., Sette A., Buchmeier M. J. HLA-A2-restricted protection against lethal lymphocytic choriomeningitis. J. Virol. 2007; 81: 2307–2317
   Google Scholar
• Bui H. H., Botten J., Fusseder N., Pasquetto V., Mothe B., Buchmeier M. J., Sette A. Protein sequence database for pathogenic arenaviruses. Immunome Res 2007; 3: 1
   Google Scholar
• Burkett M. W., Shafer-Weaver K. A., Strobl S., Baseler M., Malyguine A. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity. J. Immunother. 2005; 28: 396–402
   PubMed Web of Science ®Google Scholar
• Chen G., Tai A. K., Lin M., Chang F., Terhorst C., Huber B. T. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J. Immunol. 2005; 175: 2212–2218
   PubMed Web of Science ®Google Scholar
• Chiu C., Heaps A. G., Cerundolo V., McMichael A. J., Bangham C. R., Callan M. F. Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo. Blood 2007; 109: 1086–1094
   Google Scholar
• De Rosa S. C., Lu F. X., Yu J., Perfetto S. P., Falloon J., Moser S., Evans T. G., Koup R., Miller C. J., Roederer M. Vaccination in humans generates broad T cell cytokine responses. J. Immunol. 2004; 173: 5372–5380
   PubMedGoogle Scholar
• Ewen C. L., Rong J., Kokaji A. I., Bleackley R. C., Kane K. P. Evaluating antigen-specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay. J. Immunol. Meth. 2006; 308: 156–166
   Google Scholar
• Fuse S., Bellfy S., Yagita H., Usherwood E. J. CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J. Immunol. 2007; 178: 5227–5236
   Google Scholar
• He L., Hakimi J., Salha D., Miron I., Dunn P., Radvanyi L. A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells. J. Immunol. Meth. 2005; 304: 43–59
   PubMedGoogle Scholar
• Hermans I. F., Silk J. D., Yang J., Palmowski M. J., Gileadi U., McCarthy C., Salio M., Ronchese F., Cerundolo V. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J. Immunol. Meth. 2004; 285: 25–40
   PubMedGoogle Scholar
• Hinrichs C. S., Gattinoni L., Restifo N. P. Programming CD8+ T cells for effective immunotherapy. Curr. Opin. Immunol. 2006; 18: 363–370
   PubMed Web of Science ®Google Scholar
• Kaech S. M., Wherry E. J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2002; 2: 251–262
   PubMed Web of Science ®Google Scholar
• Kotturi M. F., Peters B., Buendia-Laysa F., Jr., Sidney J., Oseroff C., Botten J., Grey H., Buchmeier M. J., Sette A. The CD8+ T-Cell response to lymphocytic choriomeningitis virus involves the L antigen: Uncovering new tricks for an old virus. J. Virol. 2007; 81: 4928–4940
   PubMedGoogle Scholar
• Martin D. L., Weatherly D. B., Laucella S. A., Cabinian M. A., Crim M. T., Sullivan S., Heiges M., Craven S. H., Rosenberg C. S., Collins M. H., et al. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2006; 2: e77
   PubMed Web of Science ®Google Scholar
• Masopust D., Murali-Krishna K., Ahmed R. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J. Virol. 2007; 81: 2002–2011
   PubMedGoogle Scholar
• Mescher M. F., Curtsinger J. M., Agarwal P., Casey K. A., Gerner M., Hammerbeck C. D., Popescu F., Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunol. Rev. 2006; 211: 81–92
   PubMed Web of Science ®Google Scholar
• Moutaftsi M., Peters B., Pasquetto V., Tscharke D. C., Sidney J., Bui H. H., Grey H., Sette A. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol. 2006; 24: 817–819
   PubMed Web of Science ®Google Scholar
• Munks M. W., Gold M. C., Zajac A. L., Doom C. M., Morello C. S., Spector D. H., Hill A. B. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J. Immunol. 2006; 176: 3760–3766
   PubMed Web of Science ®Google Scholar
• Murali-Krishna K., Altman J. D., Suresh M., Sourdive D. J., Zajac A. J., Miller J. D., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998; 8: 177–187
   PubMed Web of Science ®Google Scholar
• Oehen S., Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 1998; 161: 5338–5346
   PubMed Web of Science ®Google Scholar
• Oehen S., Brduscha-Riem K., Oxenius A., Odermatt B. A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy. J. Immunol. Meth. 1997; 207: 33–42
   Google Scholar
• Oseroff C., Kos F., Bui H. H., Peters B., Pasquetto V., Glenn J., Palmore T., Sidney J., Tscharke D. C., Bennink J. R., et al. HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc. Natl. Acad. Sci. U S A 2005; 102: 13980–13985
   PubMedGoogle Scholar
• Prasad S. J., Farrand K. J., Matthews S. A., Chang J. H., McHugh R. S., Ronchese F. Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells. J. Immunol. 2005; 174: 90–98
   PubMed Web of Science ®Google Scholar
• Regoes R. R., Barber D. L., Ahmed R., Antia R. Estimation of the rate of killing by cytotoxic T lymphocytes. in vivo. Proc. Natl. Acad. Sci. U S A 2007; 104: 1599–1603
   Google Scholar
• Slifka M. K., Whitton J. L. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat. Immunol. 2001; 2: 711–717
   PubMed Web of Science ®Google Scholar
• Stambas J., Doherty P. C., Turner S. J. An in vivo cytotoxicity threshold for influenza A virus-specific effector and memory CD8(+) T cells. J. Immunol. 2007; 178: 1285–1292
   Google Scholar
• Stevenson P. G., Belz G. T., Altman J. D., Doherty P. C. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gammaherpesvirus infection. Eur. J. Immunol. 1999a; 29: 1059–1067
   Google Scholar
• Stevenson P. G., Belz G. T., Castrucci M. R., Altman J. D., Doherty P. C. A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc. Natl. Acad. Sci. U S A 1999b; 96: 9281–9286
   PubMed Web of Science ®Google Scholar
• Sunil-Chandra N. P., Efstathiou S., Arno J., Nash A. A. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 1992; 73: 2347–2356
   PubMed Web of Science ®Google Scholar
• Tscharke D. C., Karupiah G., Zhou J., Palmore T., Irvine K. R., Haeryfar S. M., Williams S., Sidney J., Sette A., Bennink J. R., Yewdell J. W. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 2005; 201: 95–104
   PubMed Web of Science ®Google Scholar
• Tscharke D. C., Woo W. P., Sakala I. G., Sidney J., Sette A., Moss D. J., Bennink J. R., Karupiah G., Yewdell J. W. Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice. J. Virol. 2006; 80: 6318–6323
   PubMed Web of Science ®Google Scholar
• Usherwood E. J. A new approach to epitope confirmation by sampling effector/memory T cells migrating to the lung. J. Immunol. Meth. 2002; 266: 135–142
   Google Scholar
• Zuber B., Levitsky V., Jonsson G., Paulie S., Samarina A., Grundstrom S., Metkar S., Norell H., Callender G. G., Froelich C., Ahlborg N. Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells. J. Immunol. Meth. 2005; 302: 13–25
   PubMed Web of Science ®Google Scholar